Clinical Trial

SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC

Unknown Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2024 (before its estimated June 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
To explore the safety and efficacy of neoadjuvant therapy for locally advanced rectal cancer with short course radiotherapy followed by camrelizumab combined with fluzoparib and chemotherapy
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06516445
Lead Sponsor Huazhong University of Science and Technology
Conditions Colorectal Cancer
Enrollment 33 participants
Start Date 2023-06-28
Primary Completion 2025-06-28 (estimated)
Study Completion 2026-06-28 (estimated)
Updated on ClinicalTrials.gov 2024-07-24